APA (7th ed.) Citation

Liu, J. S., & Rao, S. (2016). Long-term drug costs per life-month gained associated with first-line treatments for unresectable or metastatic melanoma. Experimental Hematology & Oncology, 5, 1. https://doi.org/10.1186/s40164-016-0039-0

Chicago Style (17th ed.) Citation

Liu, Jun S., and Sumati Rao. "Long-term Drug Costs Per Life-month Gained Associated with First-line Treatments for Unresectable or Metastatic Melanoma." Experimental Hematology & Oncology 5 (2016): 1. https://doi.org/10.1186/s40164-016-0039-0.

MLA (9th ed.) Citation

Liu, Jun S., and Sumati Rao. "Long-term Drug Costs Per Life-month Gained Associated with First-line Treatments for Unresectable or Metastatic Melanoma." Experimental Hematology & Oncology, vol. 5, 2016, p. 1, https://doi.org/10.1186/s40164-016-0039-0.